Cevdet Samikoglu
Directeur Général chez Biosplice Therapeutics, Inc.
Profil
Cevdet Samikoglu is currently the Chief Executive Officer and Director at Biosplice Therapeutics, Inc. Prior to this, he worked as a Partner at Greywolf Capital Management LP.
Postes actifs de Cevdet Samikoglu
Sociétés | Poste | Début |
---|---|---|
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Directeur Général | 01/03/2021 |
Anciens postes connus de Cevdet Samikoglu
Sociétés | Poste | Fin |
---|---|---|
Greywolf Capital Management LP
Greywolf Capital Management LP Investment ManagersFinance Greywolf Capital Management LP (Greywolf Capital) is an independent, SEC-registered investment advisor and hedge fund firm headquartered in Purchase, New York. The firm was founded in 2003 by Bob Miller, Jonathan Savitz, William Troy and James Gillespie. Greywolf Capital provides investment advisory services to (i) private investment funds that are primarily offered to institutional investors and financially sophisticated high net worth individuals and (ii) separately managed accounts, primarily for the foregoing types of investors. | Gestionnaire de Portefeuille-Actions | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Greywolf Capital Management LP
Greywolf Capital Management LP Investment ManagersFinance Greywolf Capital Management LP (Greywolf Capital) is an independent, SEC-registered investment advisor and hedge fund firm headquartered in Purchase, New York. The firm was founded in 2003 by Bob Miller, Jonathan Savitz, William Troy and James Gillespie. Greywolf Capital provides investment advisory services to (i) private investment funds that are primarily offered to institutional investors and financially sophisticated high net worth individuals and (ii) separately managed accounts, primarily for the foregoing types of investors. | Finance |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Commercial Services |